Moderna Inc.’s stock jumped 5% early Thursday, after the company’s third-quarter earnings showed an unexpected profit and ...

Biotech stocks are surging as groundbreaking neuroscience and gene therapy innovations take center stage. Amid this backdrop, ...

Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the drug's first full quarter on the market. A mere year ago, Madrigal had no ...

Ultimately, experts believe AI in drug discovery will lead to better drugs being developed faster. Here are four AI-oriented ...

Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...

We take a look at 4 Pharma & Biotech companies whose share prices rallied in October on the back of positive announcements.

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming.

Biotech stock Neurogene collapsed Tuesday after a patient experienced a serious side effect in the company's Rett syndrome ...

Still, you largely own biotech stocks for the promise of their research and development (R&D) pipeline and the company's ...

Syndax Pharmaceuticals announces positive Phase 2 trial results for revumenib in relapsed/refractory mNPM1 AML, with key ...

Biotech valuations and investing peaked in late 2021, with investors surging into the sector at the height of the Covid-19 ...

VIR's HDV and HBV treatments remain Vir's primary value drivers, with upcoming catalysts in Q4 2024 and 2025. Find out why ...